The backlash against bioequivalence and the interchangeability of brand-name and generic drugs

被引：15

作者：

Kesselheim, Aaron S. ^{[1
,2
]}

机构：

[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

来源：

CANADIAN MEDICAL ASSOCIATION JOURNAL | 2011年 / 183卷 / 12期

关键词：

D O I：

10.1503/cmaj.110808

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1350 / 1351

页数：2

共 14 条

[1] Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration [J].

Davit, Barbara M. ;

Nwakama, Patrick E. ;

Buehler, Gary J. ;

Conner, Dale P. ;

Haidar, Sam H. ;

Patel, Devvrat T. ;

Yang, Yongsheng ;

Yu, Lawrence X. ;

Woodcock, Janet .

ANNALS OF PHARMACOTHERAPY, 2009, 43 (10) :1583-1597

[2] Acute epilepsy exacerbations in patients switched between A-rated anti-epileptic drugs [J].

Devine, Scott T. ;

Weisbart, Edmond ;

Barron, John ;

Behm, Andrew .

CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (02) :455-463

[3] The risks and costs of multiple-generic substitution of topiramate [J].

Duh, M. S. ;

Paradis, P. E. ;

Latremouille-Viau, D. ;

Greenberg, P. E. ;

Lee, S. P. ;

Durkin, M. B. ;

Wan, G. J. ;

Rupnow, M. F. T. ;

LeLorier, J. .

NEUROLOGY, 2009, 72 (24) :2122-2129

[4]

EBAN K, 2009, SELF JUN

[5]

HAMBURG MA, 1139 US FOOD DRUG AD

[6]

HUCKMAN M, 2007, CNBC 1029

[7] Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease A Systematic Review and Meta-analysis [J].

Kesselheim, Aaron S. ;

Misono, Alexander S. ;

Lee, Joy L. ;

Stedman, Margaret R. ;

Brookhart, M. Alan ;

Choudhry, Niteesh K. ;

Shrank, William H. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (21) :2514-2526

[8] Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy [J].

Liow, K. ;

Barkley, G. L. ;

Pollard, J. R. ;

Harden, C. L. ;

Bazil, C. W. .

NEUROLOGY, 2007, 68 (16) :1249-1250

[9]

*NAT C STAT LEG, 2011, COND SPEC DRUG SUBST

[10]

*PRESCRIPTIONSOLUT, 2009, SURV NEARL ONE 2 DON

← 1 2 →